Asthma and chronic obstructive lung disease: a pharmacologic approach

Area of Science:

• Pulmonology
• Allergy and Immunology
• Pharmacology

Background:

• Asthma treatment paradigms are evolving, necessitating a review of current understanding.
• Inflammation and allergic responses are recognized as key factors in asthma pathogenesis.
• Existing treatment guidelines for acute and chronic asthma require updates.

Purpose of the Study:

• To review the triggers and inflammatory mechanisms of asthma.
• To outline current treatment strategies for acute and chronic asthma.
• To explore emerging concepts and novel therapeutic approaches for asthma.

Main Methods:

• Review of existing literature on asthma triggers, inflammation, and treatment.
• Analysis of the roles of sympathomimetics, theophylline, and corticosteroids in acute asthma.
• Evaluation of chronic management strategies, including inhaled corticosteroids and immunotherapy.
• Exploration of novel pharmacologic agents under investigation.

Main Results:

• Sympathomimetics remain the primary treatment for acute severe asthma.
• Corticosteroids are increasingly recommended for severe asthma management, particularly inhaled forms.
• Inflammation is a central target for chronic asthma control.
• Allergy's role in asthma perpetuation is gaining attention, with immunotherapy showing promise.
• Investigational therapies include gold, methotrexate, and intravenous gamma globulin.

Conclusions:

• Current asthma management emphasizes targeting inflammation, with inhaled corticosteroids as a first-line therapy.
• Emerging research highlights the significance of allergy in asthma and the potential of immunotherapy.
• Novel therapeutic agents are under active investigation to improve asthma control.